These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 19667620)

  • 1. Practicing effective preventive medicine. Pharmacologic interventions in coronary heart disease.
    Eisenberg DA
    Postgrad Med; 2003 Apr; 113(4 Suppl):24-30. PubMed ID: 19667620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New evidence supporting aggressive lipid lowering.
    Stein EA
    Postgrad Med; 2003 Apr; 113(4 Suppl):31-40. PubMed ID: 19667621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An urgent matter-identifying your patients' cardiovascular risk and improving their outcomes. Low-density lipoprotein cholesterol and coronary heart disease: the importance of reaching target goals with statin therapy.
    Lewis SJ
    J Fam Pract; 2009 Nov; 58(11 Suppl Urgent):S32-40. PubMed ID: 19891946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholesterol and coronary events. The current thinking.
    Jones PH
    Postgrad Med; 2003 Apr; 113(4 Suppl):5-14. PubMed ID: 19667618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reducing the risk of coronary heart disease via lipid reduction.
    Spratt KA
    J Am Osteopath Assoc; 2004 Sep; 104(9 Suppl 7):S9-13. PubMed ID: 15467018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-density lipoprotein cholesterol reduction: the end is more important than the means.
    LaRosa JC
    Am J Cardiol; 2007 Jul; 100(2):240-2. PubMed ID: 17631077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventive strategies for reducing coronary heart disease-related morbidity and mortality in patients with multiple risk factors.
    Brown WV
    J Am Osteopath Assoc; 2001 Sep; 101(9 Suppl):S6-11. PubMed ID: 11575043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The new "lower is better" lipid goals: are they achievable with today's drugs?
    Chilton RJ
    J Am Osteopath Assoc; 2002 May; 102(5 Suppl 1):S1-5. PubMed ID: 12046679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid and nonlipid benefits of statins.
    Chilton RJ
    J Am Osteopath Assoc; 2003 Jul; 103(7 Suppl 3):S12-7. PubMed ID: 12884939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid lowering treatment patterns and goal attainment in Nordic patients with hyperlipidemia.
    Svilaas A; Strandberg T; Eriksson M; Hildebrandt P; Westheim A
    Scand Cardiovasc J; 2008 Aug; 42(4):279-87. PubMed ID: 18609053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Model-based simulation to explore the cost-effectiveness of following practice guidelines for triglyceride and low-density lipoprotein cholesterol control among patients with diabetes mellitus and mixed dyslipidemia.
    Sorensen SV; Frick KD; Wade A; Simko R; Burge R
    Clin Ther; 2009 Apr; 31(4):862-79. PubMed ID: 19446159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guideline-oriented ambulatory lipid-lowering therapy of patients at high risk for cardiovascular events by cardiologists in clinical practice: the 2L cardio registry.
    Gitt AK; Juenger C; Jannowitz C; Karmann B; Senges J; Bestehorn K
    Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16(4):438-44. PubMed ID: 19369876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CHD risk equivalents and the metabolic syndrome. Trial evidence supports aggressive management.
    Thompson PD
    Postgrad Med; 2003 Aug; 114(2 Suppl):22-30. PubMed ID: 19667636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategies for optimizing lipid management.
    Ballantyne CM
    Postgrad Med; 2004 Sep; 116(3 Suppl):13-20. PubMed ID: 19667671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Achieving cholesterol goals. Current and future drug therapies.
    Jones PH
    Postgrad Med; 2003 Aug; 114(2 Suppl):14-21. PubMed ID: 19667635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reshaping the dyslipidemia management paradigm.
    Guthrie RM
    Postgrad Med; 2003 Aug; 114(2 Suppl):7-13. PubMed ID: 19667634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathophysiology of coronary heart disease: a brief review.
    Chilton RJ
    J Am Osteopath Assoc; 2004 Sep; 104(9 Suppl 7):S5-8. PubMed ID: 15467017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aggressive lipid management for cardiovascular prevention: evidence from clinical trials.
    Friday KE
    Exp Biol Med (Maywood); 2003 Jul; 228(7):769-78. PubMed ID: 12876295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The patient at risk: who should we be treating?
    Leitersdorf E
    Br J Clin Pract Suppl; 1994 Dec; (77):24-7. PubMed ID: 19496269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The importance of reaching lipid targets: statins and the prevention of atherosclerosis.
    Schwandt P
    Int J Clin Pract; 2003 Jun; 57(5):396-404. PubMed ID: 12846345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.